Evidence map›Paper›PMID 40578997›Full record

ReviewIn vivo (Athens, Greece)

Bizarre Parosteal Osteochondromatous Proliferation Revisited.

Jun Nishio, Yuki Shinohara, Shizuhide Nakayama, Mikoro Koga, Mikiko Aoki, Takamasa Koga

Abstract readReview
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun NishioSection of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan; nishio@fdcnet.ac.jp.
Yuki ShinoharaSection of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan.
Shizuhide NakayamaDepartment of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Mikoro KogaDepartment of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Mikiko AokiDepartment of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Takamasa KogaKoga Orthopaedic Clinic, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bizarre parosteal osteochondromatous proliferation (BPOP) is a rare benign surface-based bone lesion that primarily occurs in the hands and feet of young and early middle-aged adults. The lesion presents as a firm, usually painless mass of variable duration. Radiographs reveal a well-defined, pedunculated or sessile mass arising from the cortical surface of bone without altering the architecture of the underlying cortex. On magnetic resonance imaging, BPOP shows low to intermediate signal intensity on T1-weighted images and variable signal intensity on T2-weighted images. Marked enhancement is often seen after intravenous contrast administration. Histologically, the lesion is composed of an admixture of cartilage, bone and fibrous tissue. Between the cartilage and bone is a characteristic basophilic stroma, so called "blue bone". Immunohistochemistry does not play a significant role in the diagnosis of BPOP. Cytogenetic studies have demonstrated recurrent chromosomal abnormalities, including t(1;17)(q32-42;q21-23), inv(7)(q21.2-22q31.3-32) and inv(6)(p25q15). Most recently, gene rearrangements of collagen type I alpha 1 chain (

Indexed as

Bone NeoplasmsOsteochondromaCell ProliferationHumansMagnetic Resonance ImagingBizarre parosteal osteochondromatous proliferationCOL1A1COL1A2florid reactive periostitisNora lesionosteochondromareviewsubungual exostosis

Identifiers

PMID40578997
PMCPMC12223608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.